Science Market Update
Over thirty-six million Americans suffer from migraines. According to the Migraine Research Foundation, more people in the U.S. suffer from migraines than diabetes and asthma combined. The disorder ranks in the top twenty of the world’s most disabling medical conditions. Yet, migraine research has traditionally been one of the lowest-funded fields of study in medicine… Until now.Read More
When vital organs in the body, such as the lungs, begin to fail, an organ transplant can be a solution to the problem. However, receiving a transplant may have its own complications, such as the body rejecting its new organ.
Now, thanks to a generous donation of $1 million dollars from Michael and Linda Keston, researchers from the Division of Pulmonary and Critical Care Medicine at the UCLA David Geffen School of Medicine will be able to continue studying lung disease and the organ rejection commonly following a transplant.Read More
During pregnancy, much of a fetus’ development is contingent on the condition and function of the placenta. It is responsible for the transmission of substances from mother to child that are critical to early development, including blood, oxygen and nutrients, without which the fetus could not exist. Sometimes, however, environmental effects can cause deficiencies in the placenta, which can lead to harmful side effects such as preterm birth or even death.Read More
Tags: CA, University of California Los Angeles, Medical Research, California, Los Angeles, Development, UCLA, Biotechnology Vendor Showcase, NIH funding, NIH award, Southwest Region, 2016, best science tradeshows, pollution, pregnancy
Like any living organism, cancer cells rely on fuel in order to survive and grow. Unfortunately for many, the growth of cancer cells is extremely deleterious to human health. That is why a major facet of cancer research currently involves locating and preventing the mechanism for fueling cancer cells.Read More
Tags: CA, University of California Los Angeles, cancer research, California, Los Angeles, Cancer Treatment, 2015, LAVS, UCLA, Research Funding, Life Science, Biotechnology Vendor Showcase, Southwest Region, Prostate cancer
While not necessarily always the best course of treatment, the majority of men with prostate cancer will go with radiation treatment when confronted with options for treating the potentially deadly disease. Unlike other options, including surgery and chemotherapy, radiation treatment is a relatively “outpatient” procedure - with no anesthetic needed, targeted effectiveness, and relatively few short term side effects.Read More
Sometimes eradicating the tumor is only a partial defeat for cancer. Tumors release cancerous cells into the bloodstream that can form new tumors. A team at the University of California, Los Angeles has devised a clever strategy for detecting and collecting these errant cells so they can be stopped and studied to prevent further harm.Read More
Biochemists at the University of California, Los Angeles recently developed the largest molecular "cage" ever created. This "cage", a cube-like structure, was constructed from 24 copies of a single protein that has the ability to self-assemble into a cage. This newly created cage could potentially lead to new ways of delivering vaccines to infected cells.Read More
To get under the skin of a tumor is a very difficult task. If the goal is to invade tumor cells, then classic drugs are simply too large to get through. A bioresearch team at the University of California, Los Angeles is collaborating with a startup company to develop particles small enough for the job.
Have you ever lay in bed tossing and turning, wishing you could fall asleep? While most people have trouble falling asleep some nights because of a late evening coffee or a stressful day, those who suffer from chronic insomnia are at a serious health risk if they don’t get an adequate amount of sleep. Approximately 15 percent of older adults in the United States suffer chronic insomnia, which can lead the way to cardiovascular disease, hypertension, weight gain, type 2 diabetes and even an earlier death.
Life science researchers at the University of California, Los Angeles have discovered the answer to two questions whose answers have eluded insomnia and sleep researchers in the past: Can treating insomnia reduce inflammation, and what is the most effective therapy for treating insomnia? The study, published in the journal Sleep¸ shows that treating insomnia led to decreases in a known marker of inflammation called C-reactive protein (CRP).Read More